$MDGN..Medgenics priced an offering of ~5.125 mln shares of its common stock in a previously announced underwritten public offering at a price to the public of $4.10/share (MDGN) : Gross proceeds to the co from the sale of shares are expected to be approximately $21.0 million.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.